Anti-Human TNF alpha Therapeutic Antibody (Golimumab)
Recombinant monoclonal antibody to TNF alpha. Golimumab (CNTO 148) is a human monoclonal antibody which is used as an immunosuppressive drug, Golimumab targets tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF inhibitor.
Golimumab is as a once monthly subcutaneous treatment for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Golimumab is as a once monthly subcutaneous treatment for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-062 |
| Pricing | Inquiry |
| Host | Human |
| Target | TNF alpha |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in IP, IF, FuncS, FC, Neut, ELISA, WB and most other immunological methods. |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |